Ashe Carol Gail is a director of Elicio Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aptose Biosciences Inc.
7 Feb 24
4
Elicio Therapeutics, Inc.
29 Dec 23
3
Elicio Therapeutics, Inc.
7 Jun 23
4
Aptose Biosciences Inc.
23 Jan 23
4
Aptose Biosciences Inc.
20 Jan 22
4
Aptose Biosciences Inc.
6 Jan 21
4
Aptose Biosciences Inc.
13 Mar 20
4
Aptose Biosciences Inc.
3 Feb 20
4
Aptose Biosciences Inc.
3 Jan 19
3
Aptose Biosciences Inc.
21 Dec 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Feb 24 | APTO Aptose Biosciences | Director Stock Option Common Shares | Grant | Acquire A | No | No | 2 | 3,333 | 6.67 k | 3,333 |
28 Dec 23 | ELTX Elicio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 4,100 | 33.87 k | 4,100 |
19 Jan 23 | APTO Aptose Biosciences | Director Stock Option Common Shares | Grant | Acquire A | No | No | 0.66 | 100,000 | 66.00 k | 100,000 |